Ligand Pharmaceuticals Archives

2 minute read

Xeris Biopharma Announces CEO Succession Plan, John P. Shannon to Lead as New CEO

Key Highlights Paul R. Edick to retire as CEO and Chairman effective August 1, 2024. John P. Shannon…

July 14, 2024